SpringerLink
Log in

Complications in Device Therapy: Spectrum, Prevalence, and Management

  • Devices (C. Veltmann, Section Editor)
  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Cardiac implantable electronic device implant numbers are continually increasing due to the expanding indications and ageing population. This review explores the complications associated with device therapy and discusses ways to minimise and manage such complications.

Recent Findings

Complications related to device therapy contribute to mortality and morbidity. Recent publications have detailed clear guidelines for appropriate cardiac device selection, as well as consensus documents discussing care quality and optimal implantation techniques. There have also been advances in device technologies that may offer alternative options to patients at high risk of/or already having encountered a complication.

Summary

Adherence to guidelines, appropriate training, and selection of device, in addition to good surgical technique are key in reducing the burden of complications and improving acceptability of device therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Adapted from Blomstom-Lundquist et al. [18]

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. • Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42(35):3427–520. This document details the most up-to-date evidence-based recommendations for cardiac pacing and cardiac resynchronisation. It was published alongside the updated heart failure guidelines bringing these closely related fields in line with each other.

    Article  PubMed  Google Scholar 

  2. Raatikainen MJP, Arnar DO, Merkely B, Nielsen JC, Hindricks G, Heidbuchel H, et al. A decade of information on the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2017 report from the European Heart Rhythm Association. Europace. 2017;19(suppl_2):ii1–90.

    Article  PubMed  Google Scholar 

  3. Programme NCA. National Audit of Cardiac Rhythm Management Report 2021. Accessed Online Feburary 2022. 2021.

  4. Chui PW, Wang Y, Ranasinghe I, Mitiku TY, Seto AH, Rosman L, et al. Association of physician specialty with long-term implantable cardioverter-defibrillator complication and reoperations rates. Circ Cardiovasc Qual Outcomes. 2019;12(6): e005374.

    Article  PubMed  PubMed Central  Google Scholar 

  5. • Aktaa S, Abdin A, Arbelo E, Burri H, Vernooy K, Blomstrom-Lundqvist C, et al. European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology. Europace. 2022;24(1):165–72. This work relates to the development of quality indicators for care for patients undergoing device procedures in order to improve clinical outcomes.

    Article  PubMed  Google Scholar 

  6. Society BHR. Standards for implementation and follow-up of cardiac rhythm management devices in adults; 2018.

  7. Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA. Physician procedure volume and complications of cardioverter-defibrillator implantation. Circulation. 2012;125(1):57–64.

    Article  PubMed  Google Scholar 

  8. Ellenbogen KA, Hellkamp AS, Wilkoff BL, Camunas JL, Love JC, Hadjis TA, et al. Complications arising after implantation of DDD pacemakers: the MOST experience. Am J Cardiol. 2003;92(6):740–1.

    Article  PubMed  Google Scholar 

  9. Kirkfeldt RE, Johansen JB, Nohr EA, Jorgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35(18):1186–94.

    Article  PubMed  Google Scholar 

  10. Schuchert A, Muto C, Maounis T, Frank R, Boulogne E, Polauck A, et al. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker. Europace. 2013;15(1):71–6.

    Article  PubMed  Google Scholar 

  11. Dorwarth U, Frey B, Dugas M, Matis T, Fiek M, Schmoeckel M, et al. Transvenous defibrillation leads: high incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol. 2003;14(1):38–43.

    Article  PubMed  Google Scholar 

  12. Sridhar AR, Yarlagadda V, Yeruva MR, Kanmanthareddy A, Vallakati A, Dawn B, et al. Impact of haematoma after pacemaker and CRT device implantation on hospitalization costs, length of stay, and mortality: a population-based study. Europace. 2015;17(10):1548–54.

    Article  PubMed  Google Scholar 

  13. Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP, et al. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation. 2009;119(8):1078–84.

    Article  PubMed  Google Scholar 

  14. Armaganijan LV, Toff WD, Nielsen JC, Andersen HR, Connolly SJ, Ellenbogen KA, et al. Are elderly patients at increased risk of complications following pacemaker implantation? A meta-analysis of randomized trials. Pacing Clin Electrophysiol. 2012;35(2):131–4.

    Article  PubMed  Google Scholar 

  15. Tsai V, Goldstein MK, Hsia HH, Wang Y, Curtis J, Heidenreich PA, et al. Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States. Circ Cardiovasc Qual Outcomes. 2011;4(5):549–56.

    Article  PubMed  Google Scholar 

  16. Udo EO, van Hemel NM, Zuithoff NP, Kelder JC, Crommentuijn HA, Koopman-Verhagen AM, et al. Long-term outcome of cardiac pacing in octogenarians and nonagenarians. Europace. 2012;14(4):502–8.

    Article  PubMed  Google Scholar 

  17. Lim YM, Uhm JS, Kim M, Kim IS, ** MN, Yu HT, et al. Subclinical cardiac perforation by cardiac implantable electronic device leads detected by cardiac computed tomography. BMC Cardiovasc Disord. 2021;21(1):346.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Blomstrom-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020;41(21):2012–32.

    Article  PubMed  Google Scholar 

  19. Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122(16):1553–61.

    Article  PubMed  Google Scholar 

  20. Clementy N, Carion PL, Leotoing L, Lamarsalle L, Wilquin-Bequet F, Brown B, et al. Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study. Europace. 2018;20(12):1974–80.

    Article  PubMed  Google Scholar 

  21. Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace. 2015;17(5):767–77.

    Article  PubMed  Google Scholar 

  22. Green AR, Leff B, Wang Y, Spatz ES, Masoudi FA, Peterson PN, et al. Geriatric conditions in patients undergoing defibrillator implantation for prevention of sudden cardiac death: prevalence and impact on mortality. Circ Cardiovasc Qual Outcomes. 2016;9(1):23–30.

    Article  PubMed  Google Scholar 

  23. Ozcan KS, Osmonov D, Altay S, Donmez C, Yildirim E, Turkkan C, et al. Pacemaker implantation complication rates in elderly and young patients. Clin Interv Aging. 2013;8:1051–4.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kirkfeldt RE, Johansen JB, Nohr EA, Moller M, Arnsbo P, Nielsen JC. Pneumothorax in cardiac pacing: a population-based cohort study of 28,860 Danish patients. Europace. 2012;14(8):1132–8.

    Article  PubMed  Google Scholar 

  25. Al-Ahmad A, Natale A, Wang PJ, Daubert JP, Padeletti L. How-to manual for pacemaker and ICD devices : procedures and programming. Hoboken, NJ: John Wiley & Sons Inc; 2018.

    Book  Google Scholar 

  26. • Burri H, Starck C, Auricchio A, Biffi M, Burri M, D’Avila A, et al. EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS). Europace. 2021;23(7):983–1008. This expert consensus discusses the key aspects of device implantation technique to ensure good outcomes and reduced risk of complication.

    Article  PubMed  Google Scholar 

  27. Da Costa A, Lelievre H, Kirkorian G, Celard M, Chevalier P, Vandenesch F, et al. Role of the preaxillary flora in pacemaker infections: a prospective study. Circulation. 1998;97(18):1791–5.

    Article  PubMed  Google Scholar 

  28. Mittal S, Shaw RE, Michel K, Palekar R, Arshad A, Musat D, et al. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope. Heart Rhythm. 2014;11(4):595–601.

    Article  PubMed  Google Scholar 

  29. Darouiche R, Mosier M, Voigt J. Antibiotics and antiseptics to prevent infection in cardiac rhythm management device implantation surgery. Pacing Clin Electrophysiol. 2012;35(11):1348–60.

    Article  PubMed  Google Scholar 

  30. Krahn AD, Longtin Y, Philippon F, Birnie DH, Manlucu J, Angaran P, et al. Prevention of arrhythmia device infection trial: the PADIT trial. J Am Coll Cardiol. 2018;72(24):3098–109.

    Article  PubMed  Google Scholar 

  31. Tarakji KG, Mittal S, Kennergren C, Corey R, Poole JE, Schloss E, et al. Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med. 2019;380(20):1895–905.

    Article  CAS  PubMed  Google Scholar 

  32. Mittal S, Wilkoff BL, Kennergren C, Poole JE, Corey R, Bracke FA, et al. The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: long-term follow-up. Heart Rhythm. 2020;17(7):1115–22.

    Article  PubMed  Google Scholar 

  33. Wilkoff BL, Boriani G, Mittal S, Poole JE, Kennergren C, Corey GR, et al. Cost-effectiveness of an antibacterial envelope for cardiac implantable electronic device infection prevention in the US healthcare system from the WRAP-IT trial. Circ Arrhythm Electrophysiol. 2020;13(10): e008503.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Essebag V, Verma A, Healey JS, Krahn AD, Kalfon E, Coutu B, et al. Clinically significant pocket hematoma increases long-term risk of device infection: Bruise Control Infection Study. J Am Coll Cardiol. 2016;67(11):1300–8.

    Article  PubMed  Google Scholar 

  35. Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, et al. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med. 2013;368(22):2084–93.

    Article  CAS  PubMed  Google Scholar 

  36. Birnie DH, Healey JS, Wells GA, Ayala-Paredes F, Coutu B, Sumner GL, et al. Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2). Eur Heart J. 2018;39(44):3973–9.

    Article  CAS  PubMed  Google Scholar 

  37. Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG, et al. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace. 2021;23(10):1612–76.

    Article  PubMed  Google Scholar 

  38. Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH, Dellinger EP, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med. 2009;360(5):491–9.

    Article  CAS  PubMed  Google Scholar 

  39. Ziacchi M, Massaro G, Angeletti A, Statuto G, Diemberger I, Martignani C, et al. Preoperative checklist to reduce the risk of cardiac implantable electronic device infections. Pacing Clin Electrophysiol. 2022;45(2):262–9.

    Article  PubMed  Google Scholar 

  40. WHO. Global Guidelines for the Prevention of Surgical Site Infection. WHO Document Production Services. 2016.

  41. Mittal S, Wilkoff BL, Poole JE, Kennergren C, Wright DJ, Berman BJ, et al. Low-temperature electrocautery reduces adverse effects from secondary cardiac implantable electronic device procedures: insights from the WRAP-IT trial. Heart Rhythm. 2021;18(7):1142–50.

    Article  PubMed  Google Scholar 

  42. Bongiorni MG, Proclemer A, Dobreanu D, Marinskis G, Pison L, Blomstrom-Lundqvist C, et al. Preferred tools and techniques for implantation of cardiac electronic devices in Europe: results of the European Heart Rhythm Association survey. Europace. 2013;15(11):1664–8.

    Article  PubMed  Google Scholar 

  43. Benz AP, Vamos M, Erath JW, Hohnloser SH. Cephalic vs. subclavian lead implantation in cardiac implantable electronic devices: a systematic review and meta-analysis. Europace. 2019;21(1):121–9.

    Article  PubMed  Google Scholar 

  44. Sassone B, Valzania C, Laffi M, Virzi S, Luzi M, Task Force on Imaging of the Italian Association of A, et al. Axillary vein access for antiarrhythmic cardiac device implantation: a literature review. J Cardiovasc Med (Hagerstown). 2021;22(4):237–45.

  45. Burri H, Sunthorn H, Dorsaz PA, Shah D. Prospective study of axillary vein puncture with or without contrast venography for pacemaker and defibrillator lead implantation. Pacing Clin Electrophysiol. 2005;28(Suppl 1):S280–3.

    Article  PubMed  Google Scholar 

  46. Yang F, Kulbak G. A new trick to a routine procedure: taking the fear out of the axillary vein stick using the 35 degrees caudal view. Europace. 2015;17(7):1157–60.

    Article  PubMed  Google Scholar 

  47. Cano O, Andres A, Alonso P, Osca J, Sancho-Tello MJ, Olague J, et al. Incidence and predictors of clinically relevant cardiac perforation associated with systematic implantation of active-fixation pacing and defibrillation leads: a single-centre experience with over 3800 implanted leads. Europace. 2017;19(1):96–102.

    PubMed  Google Scholar 

  48. Luria DM, Feinberg MS, Gurevitz OT, Bar-Lev DS, Granit C, Tanami N, et al. Randomized comparison of J-shaped atrial leads with and without active fixation mechanism. Pacing Clin Electrophysiol. 2007;30(3):412–7.

    Article  PubMed  Google Scholar 

  49. Hattori M, Naruse Y, Oginosawa Y, Matsue Y, Hanaki Y, Kowase S, et al. Prognostic impact of lead tip position confirmed via computed tomography in patients with right ventricular septal pacing. Heart Rhythm. 2019;16(6):921–7.

    Article  PubMed  Google Scholar 

  50. Shenthar J, Rai MK, Chakali SS, Pillai V, Delhaas T. Computed tomography validated right ventricular mid-septal lead implantation using right ventricular angiography. J Arrhythm. 2021;37(5):1131–8.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Osmancik P, Stros P. Close proximity of left anterior descending artery to the right ventricular lead apparently implanted into the mid-septum. Indian Pacing Electrophysiol J. 2014;14(2):83–6.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Liang JJ, Killu AM, Osborn MJ, Jaffe AS. Pacemaker lead perforation causing hemopericardium eight years after implantation. Indian Heart J. 2013;65(3):331–3.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green UM, Carrillo R, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14(12):e503–51.

    Article  PubMed  Google Scholar 

  54. van Gelder BM, Bracke FA. Current of injury (COI) pattern recorded from catheter delivered active fixation pacing leads. Pacing Clin Electrophysiol. 2008;31(6):786–7; author reply 7.

  55. Henrikson CA, Leng CT, Yuh DD, Brinker JA. Computed tomography to assess possible cardiac lead perforation. Pacing Clin Electrophysiol. 2006;29(5):509–11.

    Article  PubMed  Google Scholar 

  56. RavAcha M, Rafael A, Keaney JJ, Elitzur Y, Danon A, Shauer A, et al. The management of cardiac implantable electronic device lead perforations: a multicentre study. Europace. 2019;21(6):937–43.

    Article  Google Scholar 

  57. Migliore F, Zorzi A, Bertaglia E, Leoni L, Siciliano M, De Lazzari M, et al. Incidence, management, and prevention of right ventricular perforation by pacemaker and implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol. 2014;37(12):1602–9.

    Article  PubMed  Google Scholar 

  58. Burri H, Starck C. EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS)-a role for postoperative ultrasound? Authors’ reply. Europace. 2021.

  59. Bull A FF, Wright D P204 Incidence and outcomes of pneumothorax secondary to cardiac device insertion. Thorax 2021;76:A200–A201.

  60. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007;116(12):1349–55.

    Article  PubMed  Google Scholar 

  61. Tompkins C, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE, et al. Dual antiplatelet therapy and heparin “bridging” significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol. 2010;55(21):2376–82.

    Article  PubMed  Google Scholar 

  62. Tarakji KG, Korantzopoulos P, Philippon F, Biffi M, Mittal S, Poole JE, et al. Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis. Heart Rhythm. 2021;18(12):2080–6.

    Article  PubMed  Google Scholar 

  63. Juneau D, Golfam M, Hazra S, Zuckier LS, Garas S, Redpath C, et al. Positron emission tomography and single-photon emission computed tomography imaging in the diagnosis of cardiac implantable electronic device infection: a systematic review and meta-analysis. Circ Cardiovasc Imaging. 2017;10(4).

  64. Bongiorni MG, Kennergren C, Butter C, Deharo JC, Kutarski A, Rinaldi CA, et al. The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) registry of transvenous lead extraction outcomes. Eur Heart J. 2017;38(40):2995–3005.

    Article  PubMed  Google Scholar 

  65. Viganego F, O’Donoghue S, Eldadah Z, Shah MH, Rastogi M, Mazel JA, et al. Effect of early diagnosis and treatment with percutaneous lead extraction on survival in patients with cardiac device infections. Am J Cardiol. 2012;109(10):1466–71.

    Article  PubMed  Google Scholar 

  66. Reddy VY, Exner DV, Cantillon DJ, Doshi R, Bunch TJ, Tomassoni GF, et al. Percutaneous implantation of an entirely intracardiac leadless pacemaker. N Engl J Med. 2015;373(12):1125–35.

    Article  CAS  PubMed  Google Scholar 

  67. El-Chami MF, Al-Samadi F, Clementy N, Garweg C, Martinez-Sande JL, Piccini JP, et al. Updated performance of the Micra transcatheter pacemaker in the real-world setting: a comparison to the investigational study and a transvenous historical control. Heart Rhythm. 2018;15(12):1800–7.

    Article  PubMed  Google Scholar 

  68. Knops RE, OldeNordkamp LRA, Delnoy PHM, Boersma LVA, Kuschyk J, El-Chami MF, et al. Subcutaneous or transvenous defibrillator therapy. N Engl J Med. 2020;383(6):526–36.

    Article  PubMed  Google Scholar 

  69. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115(19):2474–80.

    Article  PubMed  Google Scholar 

  70. Rordorf R, Casula M, Pezza L, Fortuni F, Sanzo A, Savastano S, et al. Subcutaneous versus transvenous implantable defibrillator: an updated meta-analysis. Heart Rhythm. 2021;18(3):382–91.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Liverpool Heart and Chest Hospital NHS Foundation Trust, Thomas Drive, Liverpool, L14 3PE, UK

    J. Llewellyn, D. Garner & A. Rao

  2. Wirral University Teaching Hospital NHS Foundation Trust, Arrowe Park Road, Upton, Wirral, CH49 5PE, UK

    D. Garner

Authors
  1. J. Llewellyn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Garner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Llewellyn.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Devices.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Llewellyn, J., Garner, D. & Rao, A. Complications in Device Therapy: Spectrum, Prevalence, and Management. Curr Heart Fail Rep 19, 316–324 (2022). https://doi.org/10.1007/s11897-022-00563-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-022-00563-0

Keywords

Search

Navigation